ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Sandoz Group Ag

Sandoz Group Ag (0SAN)

0.00
0.00
(0.00%)
Closed January 30 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
-
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
0.00
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
9.65B
Net Profit
77M

About Sandoz Group Ag

Sector
Med, Dental, Hosp Eq-whsl
Industry
Med, Dental, Hosp Eq-whsl
Website
Headquarters
Rotkreuz, Che
Founded
-
Sandoz Group Ag is listed in the Med, Dental, Hosp Eq-whsl sector of the London Stock Exchange with ticker 0SAN. The last closing price for Sandoz was -. Over the last year, Sandoz shares have traded in a share price range of CHF 0.00 to CHF 0.00.

Sandoz currently has 0 shares outstanding.

0SAN Latest News

Sandoz to confirm strategic roadmap and highlight pipeline catalysts at 43rd Annual J.P. Morgan Healthcare Conference

Sandoz to confirm strategic roadmap and highlight pipeline catalysts at 43rd Annual J.P. Morgan Healthcare Conference MEDIA RELEASE Strong first year as standalone company; global leader Sandoz...

Sandoz takes further steps to resolve legacy US Generic Drug Antitrust Class Action Litigation

Sandoz takes further steps to resolve legacy US Generic Drug Antitrust Class Action Litigation Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz takes further steps...

Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio

Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio MEDIA RELEASE Afqlir® (aflibercept) approved to treat various retinal...

Sandoz reports third-quarter and nine-month 2024 sales

Sandoz reports third-quarter and nine-month 2024 sales Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Strong third-quarter biosimilars growth of 37% in...

Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further strengthening US biosimilar position

Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further strengthening US biosimilar position Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Enzeevu™...

Sandoz reports second-quarter sales and half-year 2024 results

Sandoz reports second-quarter sales and half-year 2024 results Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Strong double-digit growth in biosimilars of...

Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases

Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat chronic inflammatory diseases Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz launches...

FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US

FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules FDA approves biosimilar...

Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe

Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe   Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing...

Sandoz reports first quarter 2024 sales

Sandoz reports first quarter 2024 sales Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Strong first quarter performance, with net sales [1] of USD 2.5...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

0SAN - Frequently Asked Questions (FAQ)

What is the current Sandoz share price?
The current share price of Sandoz is CHF 0.00
What is the 1 year trading range for Sandoz share price?
Sandoz has traded in the range of CHF 0.00 to CHF 0.00 during the past year
What is the reporting currency for Sandoz?
Sandoz reports financial results in USD
What is the latest annual turnover for Sandoz?
The latest annual turnover of Sandoz is USD 9.65B
What is the latest annual profit for Sandoz?
The latest annual profit of Sandoz is USD 77M
What is the registered address of Sandoz?
The registered address for Sandoz is SUURSTOFFI 14, ROTKREUZ, ROTKREUZ, 6343
What is the Sandoz website address?
The website address for Sandoz is www.sandoz.com
Which industry sector does Sandoz operate in?
Sandoz operates in the MED, DENTAL, HOSP EQ-WHSL sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0A2IH World Group Ltd
$ 0.00
(0.00%)
0
0A2DCrh Plc
$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
$ 67.30
(0.00%)
466
0A2IH World Group Ltd
$ 0.00
(0.00%)
0
0A2DCrh Plc
$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
$ 67.30
(0.00%)
466
0R0XTesla Inc
$ 393.90
(0.00%)
6.52k
0K8DNokia Oyj
$ 6.24
(0.00%)
6.35k
0QYPMicrosoft Corp
$ 444.50
(0.00%)
3.64k
0R24Intel Corp
$ 19.89
(0.00%)
2.1k
0M42Asml Holding Nv
$ 202.51
(0.00%)
660

Discussion

View Full Feed
gdl gdl 13 minutes ago
Middle of a despot's total control of this country and you only see profits. Like a pandemic declared and everyone ignored it. NO ONE can ever argue the facts on Trump, can they. they might approve or think it benefits them BUT not that he is a MONSTER.

Trump has 2 years to fix the
SPY
rbtree rbtree 18 minutes ago
Ummm, hate to break it to ya, but that is old news from over a year ago...

Meanwhile, this pig bounces between .000001 and .0001... does it even have a bid anymore?
KEGS
jeunke22 jeunke22 22 minutes ago
Just to prove that we need more low latency, bandwidth and speed …. This is the answer to a simple question:
“ Sorry, DeepSeek search service is busy. Please disable search or try again later.”
LWLG
gdl gdl 26 minutes ago
Not only has all 3 branches of government greedily abandoned their pledge they also have lost their souls. I warned, no insisted this was happening. it spells the end of our Republic and end of the stock market. no not for a year or 5 but for decades. The godlike Trump flexes and extends his muscl
RuudSaltis RuudSaltis 31 minutes ago
That’s why he needs only 6 months….! He has a razer sharp plan. It’s amazing how he communicates also one on one with shareholders…
LWLG
wagner wagner 31 minutes ago
I would bet no smart money in before the Exim in on stage... 
NB
Truenorth2016 Truenorth2016 34 minutes ago
Just a Reminder to you and anyone lurking, we just saw the Quantum Computing Healthcare stock RG*ti run from .66 cents to $21.00 in a few months. What people need to understand is GCAN already told us they are being approach by companies for a Quantum Computing /AI merger "BUT" I the CEO never told
GCAN
ramfan60 ramfan60 37 minutes ago
What's wrong with the wingnut? You must be happy with the wonderful job our FDA and NIH have done regulating our food and nutrition over the past 50 years. RFK is passionate about Making America Healthy Again......I'm all for it and he can't get confirmed fast enough as far as I'm concerned.
AMRN
ron_66271 ron_66271 44 minutes ago
Thank for Supporting My Argument.

JPM didn’t have the money to cover Lehman’s ‘Market to Market’ of $17 Billion on September 14th.

Need more?

“BlackRock?”
Why…


All Classes are in the Money.



Ron
JPM
Zorax Zorax 44 minutes ago
He's going to sell them shitface bibles.
Doc logic Doc logic 45 minutes ago
exwannabe,

Simply put: Crossover to an active substance instead of placebo required that the active substance being utilized in the crossover be measured against a comparable group being treated with anything other than a known active substance. Comparators had to be changed when SO
NWBO
ron_66271 ron_66271 55 minutes ago
CTS are in the Same Camp as Preferred Shares.

Securitized by Derivative Contracts.

You didn’t understand the Derivative Market Meltdown of 2008.

Lehman’s wasn’t the problem.
JPM was.



Ron
JPM
littlejohn littlejohn 1 hour ago
Traders who played other big names for

Wednesday could start back in

here on the cheapies...

META and MSFT make a lot of money...

And can spend on Ai - R and D...

Seems a good money flow watch...

so we watch..
MSFT
hbhmb hbhmb 1 hour ago
You are right. To much going on behind the scenes. Also the volume ( or lack of such) is causing the swings allowing flippers to flip
Hopefully the next quarters financials will continue improving and with the new web site am hoping we start moving nicely.
AIAD
Wrangler1 Wrangler1 1 hour ago
Wonder why he's deleting posts? Probably  because he realizes he is wrong once again. What an absolute joke. 
WDLF
Golfnut3 Golfnut3 1 hour ago
Thanks for the input...
ALYI
littlejohn littlejohn 1 hour ago
Fine idea, put sellers on 28 turned bullish

on Wednesday with big volume...

https://www.barchart.com/stocks/quotes/SMCI/options?expiration=2025-01-31-w&moneyness=20

those are willing share buyers at 28

if they get exercised with a close on
SMCI
trader53 trader53 1 hour ago
DPLS 0.0004 - Short Squeeze Soon!


I'll Alert you of stocks to Buy,
before the Run happens !

https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000
________________________________________________


https://
DPLS MFI
Plato_ Plato_ 1 hour ago
https://investorshub.advfn.com/uimage/uploads/2025/1/30/jkzcuLinkedIn.png
About us

VeeMost Technologies Inc. is your trusted partner in delivering innovative, customer-focused IT solutions designed to empower your business. As a minority-owned technology provider,
GDVM
blackcat blackcat 1 hour ago
Pretty horrifying situation. Not something you'd think could happen- although it was night and it is a busy airport.
dinogreeves dinogreeves 1 hour ago
SMCI after the report it will get to the right valuation with time.
SMCI
dinogreeves dinogreeves 1 hour ago
DeepSeek is fake.
SMCI
toogoodfella toogoodfella 1 hour ago
IF YOU THINK THE BALANCE SHEET IS WRONG, BE A WHISLE BLOWER
YOULL BECOME VERY FAMOUS

LEHNQ

Your Recent History

Delayed Upgrade Clock